Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) EBIT Margin (2023)

Sagimet Biosciences has reported EBIT Margin over the past 1 years, most recently at 372.6% for Q3 2023.

  • Quarterly results put EBIT Margin at 372.6% for Q3 2023, changed N/A from a year ago — trailing twelve months through Jun 2024 was 1813.75% (changed N/A YoY), and the annual figure for FY2023 was 1537.0%, changed.
  • EBIT Margin for Q3 2023 was 372.6% at Sagimet Biosciences.
  • Over the last five years, EBIT Margin for SGMT hit a ceiling of 372.6% in Q3 2023 and a floor of 372.6% in Q3 2023.